Developer of a platform for the discovery and development of targeted therapies for cancer. It uses AI to identify and characterize ecDNA which is a mediator of oncogenic gene amplification and a potent driver of tumor evolution. It enables the development of therapies that specifically target ecDNA for cancer patients.
← All startups
Econic Biosciences
Series BDeveloper of a platform for the discovery and development of targeted therapies for cancer. It uses AI to identify and characterize ecDNA which is a mediator of oncogenic gene amplification and a potent driver of tumor evolution. It enables the development of therapies that specifically target ecDNA for cancer patients.
About
Institutional investors
SR OneGenelle Capital
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ See who's investing in HealthTech — full fund directory with check size and geography.